and Human Services (HHS)
EXPIRED
Participating Organization(s) |
National Institutes of Health (NIH) |
National Institute of Diabetes and Digestive and Kidney
Diseases (NIDDK) |
|
Funding Opportunity Title |
Career Development Programs in Diabetes Research for Pediatric Endocrinologists (K12) |
Activity Code |
K12 Physician Scientist Award (Program) (PSA) |
Announcement Type |
New |
Related Notices |
|
Funding Opportunity Announcement (FOA) Number |
RFA-DK-11-006 |
Companion FOA |
None |
Only one application per institution is allowed, as defined in Section III. 3. Additional Information on Eligibility. |
|
Catalog of Federal Domestic Assistance (CFDA) Number(s) |
93.847 |
FOA Purpose |
To foster the development of a diverse and highly trained workforce of pediatric endocrinologists to assume leadership roles related to the Nation’s biomedical and behavioral research efforts in the area of pediatric diabetes, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) invites applications for the establishment of institutional career development programs in diabetes research for pediatric endocrinologists. The NIDDK will award physician scientist career development program (K12) grants to eligible institutions to provide a program to prepare pediatricians, selected by the institution, for careers in pediatric endocrinology research related to diabetes. |
Posted Date |
February 28, 2011 |
Open Date (Earliest Submission Date) |
March 28, 2011 |
Letter of Intent Due Date |
March 28, 2011 |
Application Due Date(s) |
April 28, 2011, by 5:00 PM local time of applicant organization. |
AIDS Application Due Date(s) |
Not Applicable |
Scientific Merit Review |
July/August 2011 |
Advisory Council Review |
October, 2011 |
Earliest Start Date(s) |
December, 2011 |
Expiration Date |
April 29, 2011 |
Due Dates for E.O. 12372 |
Not Applicable |
Required Application Instructions
It is critical that applicants follow the instructions in the SF 424 (R&R) Application Guide especially the Supplemental Instructions to the SF424 (R&R) for Preparing Institutional Ruth L. Kirschstein National Research Service Award (NRSA) Application, except where to do otherwise (in this FOA or in a Notice from the NIH Guide for Grants and Contracts ). Conformance to all requirements (both in the Application Guide and the FOA) is required and strictly enforced. Applicants must read and follow all application instructions in the Application Guide as well as any program-specific instructions noted in Section IV. When the program-specific instructions deviate from those in the Application Guide, follow the program-specific instructions. Applications that do not comply with these instructions may be delayed or not accepted for review.
Part 1. Overview Information
Part 2. Full Text of the Announcement
Section I. Funding Opportunity Description
Section II. Award Information
Section III. Eligibility Information
Section IV. Application and Submission
Information
Section V. Application Review Information
Section VI. Award Administration Information
Section VII. Agency Contacts
Section VIII. Other Information
The overall goal of the NIH Research Career Development
programs is to help ensure that a diverse pool of highly trained scientists is
available in appropriate scientific disciplines to address the Nation s
biomedical, behavioral, and clinical needs. More
information about Career programs may be found at the NIH Extramural Training Mechanisms website.
This FOA encourages applications from organizations that propose creative and
innovative institutional research career development programs in diabetes
research for pediatric endocrinologists.
The proposed institutional research career development program may complement
other, ongoing research training and career development programs at the
applicant institution, but the proposed career development experiences must be
distinct from those career development programs currently receiving Federal
support.
Pediatric diabetes, including type 1 diabetes, type 2 diabetes (formerly almost exclusively a disease of adults which is now being reported with increasing frequency in children), and other rarer forms of diabetes in youth, subjects children to the risk of devastating complications over time, including accelerated cardiovascular disease, kidney failure, blindness, neuropathy, and amputation. Management of diabetes in children is particularly arduous, with suboptimal glycemic control increasing the risk of long-term complications and intensive therapy to optimize glucose levels associated with substantial risk of hypoglycemia. Effective therapy for pediatric diabetes requires an exceptional level of effort from the children, their families, and their healthcare providers. These extraordinary clinical care demands make it particularly challenging for pediatric endocrinologists involved in diabetes care to pursue research careers. Although there has been considerable recent progress in understanding the etiology and pathogenesis of pediatric diabetes and in developing improved therapies, we still cannot prevent or cure these disorders. Thus, it is imperative to enhance the diabetes research training and career development of pediatric endocrinologists to create the cadre of skilled investigators needed to build upon the foundation of current basic and clinical knowledge and to develop new approaches to the treatment, prevention and cure of pediatric diabetes.
The NIDDK intends to provide support for career development programs in pediatric diabetes at institutions that have environments, mentors and programs that will make them particularly effective in enhancing the number of independent investigators contributing to research in pediatric diabetes.
To foster the development of a diverse and highly trained workforce of pediatric endocrinologists to assume leadership roles related to the Nation’s biomedical and behavioral research efforts in the area of pediatric diabetes, the NIDDK invites applications for the establishment of institutional career development programs in diabetes research for pediatric endocrinologists. The NIDDK will award physician scientist career development program (K12) grants to eligible institutions to provide an integrated program to prepare pediatricians, selected by the institution, for careers in pediatric endocrinology research related to diabetes. In combination with existing training programs and grants, these awards will establish multilevel (fellow and junior faculty ) training and career development programs. Attracting, training and retaining the best and brightest new researchers to the study of diabetes are included in the recommendations of the NIH Diabetes Strategic Plan.
Physician scientist career development programs (K12) assist in the transition of clinical investigators to an independent research career. These institutional mentored research career development awards will allow participants up to three years of supervised research experience that may combine didactic studies with laboratory or patient-oriented research.
The K12 programs will provide an opportunity for research career development after the clinical fellowship years to facilitate the transition to a fully-trained independent investigator. Moreover, the institutions receiving these awards will be encouraged to interact with one another and to provide opportunities for career development pathways involving more than one institution.
Funding Instrument |
Grant |
Application Types Allowed |
New The OER Glossary and the SF 424 (R&R) Application Guide provide details on these application types. |
Funds Available and Anticipated Number of Awards |
The number of awards is contingent upon NIH appropriations, and the submission of a sufficient number of meritorious applications. The estimated amount of funds available for support of 4-5 programs awarded as a result of this announcement is $2.5M for fiscal year 2011. Although the financial plans of the NIDDK provide support for the first three years of this program, awards pursuant to this FOA, particularly in years 4 to 5 of the awards, are contingent upon the availability of funds.. |
Award Budget |
Application budgets need to reflect actual needs of the proposed program. |
Award Project Period |
The project period duration for this funding opportunity may not exceed five years.. |
T and D only
Personnel Costs |
Individuals designing, directing, and implementing the career development program may request salary and fringe benefits appropriate for the person months devoted to the program. Salary for the PD/PI will be provided for levels of effort up to 1.2 person months (10 % of full-time professional effort). Salaries requested may not exceed the levels commensurate with the institution's policy for similar positions and may not exceed the congressionally mandated cap. If mentoring interactions and other activities with scholars are considered a regular part of an individual's academic duties, then mentoring and other interactions with scholars are non-reimbursable from grant funds. Limited program-related administrative and clerical salary costs associated distinctly with the program that are not normally provided by the applicant organization may be direct charges to the grant only when specifically identified and justified. These expenses must be itemized in Sections A and B, as appropriate, of the R&R Budget. |
Participant Costs |
Scholars are those individuals who benefit from the proposed activities and experiences involved in the career development program. Scholar costs must be justified as specifically required for the proposed career development program and based on institutional policies for salaries paid to individuals in similar positions, regardless of the source of funds. Salary support of up to $90,000 each year, plus the appropriate fringe benefits, may be requested for each K12 scholar. The scholar is required to devote a minimum level of effort of 9 person months (75% of full-time professional effort). The institution may supplement the NIDDK contribution; however, the supplementation may not be from Federal funds unless specifically authorized by the Federal program from which such funds are derived. In no case may PHS funds be used for salary supplementation. Institutional salary supplementation may not require extra duties or responsibilities that would interfere with the purpose of this award. The total salary requested must be based on a full-time, 12-month appointment. Research and Development Support: Up to $50,000 per scholar may be requested for the following types of expenses: (a) research supplies, equipment and technical personnel; (b) tuition and fees related to didactic courses or career development; (c) travel to research meetings or training; and, (d) statistical and computational services including personnel and computer time. All expenses must be directly related to the proposed research career development program. These expenses must be itemized in the proposed budget.. |
Other Program Related Expenses |
Consultant costs, equipment, supplies, travel for key persons, and other program-related expenses may be included in the proposed budget. These expenses must be justified as specifically required by the proposed program and must not duplicate items generally available at the applicant institution.. |
Indirect Costs |
Indirect Costs (also known as Facilities & Administrative [F&A] Costs) are reimbursed at 8% of modified total direct costs (exclusive of tuition and fees and expenditures for equipment), rather than on the basis of a negotiated rate agreement. |
NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made in response to this FOA.
Higher Education Institutions:
The following types of Higher Education Institutions are always encouraged to apply for NIH support as Public or Private Institutions of Higher Education:
Nonprofits Other Than Institutions of Higher Education
Governments
Other
Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Foreign (non-U.S.) components of U.S. Organizations are not allowed.
All Program Directors/Principal Investigators (PD/PIs) must
also work with their institutional officials to register with the eRA Commons
or ensure their existing eRA Commons account is affiliated with the eRA Commons
account of the applicant organization.
All registrations must be completed by the application due date.
The sponsoring institution must assure support for
the proposed program. Appropriate institutional commitment to the program
includes the provision of adequate staff, facilities, and educational resources
that can contribute to the planned program.
The applicant institution must have
strong, high quality research
programs in basic and/or clinical diabetes, including research with a focus on type 1 diabetes. The
institution must also have the requisite faculty and facilities on site
to conduct the proposed institutional program. In many cases, it is
anticipated that the proposed program will complement other ongoing career
development programs occurring at the applicant institution and that a
substantial number of program faculty will have active research projects in
which participating scholars may gain relevant experiences consistent with
their research interests and goals. Institutions with existing programs must
explain what distinguishes this program from the others, how their programs
will synergize with one another, if applicable, and make it clear that the pool
of faculty, potential scholars, and resources are robust enough to support
additional programs.
Applicants from institutions that have an NIDDK Diabetes Research Center [i.e. Diabetes Endocrinology Research Center (DERC), or Diabetes Research and Training Center (DRTC)] or a Clinical and Translational Science Award (CTSA) may wish to identify these centers as a resource for conducting the proposed research. In such a case, a letter of agreement from the PD/PI should be included with the application.
Applicant organizations must complete the following registrations
as described in the SF 424 (R&R) Application Guide to be eligible to apply
for or receive an award. Applicants must have a valid Dun and Bradstreet
Universal Numbering System (DUNS) number in order to begin each of the
following registrations.
All Program Directors/Principal Investigators (PD/PIs) must
also work with their institutional officials to register with the eRA Commons
or ensure their existing eRA Commons account is affiliated with the eRA Commons
account of the applicant organization.
All registrations must be completed by the application due date. Applicant
organizations are strongly encouraged to start the registration process at
least four (4) weeks prior to the application due date.
Any individual(s) with the skills, knowledge, and resources
necessary to carry out the proposed research as the Project Director/Principal
Investigator (PD/PI) is invited to work with his/her organization to develop an
application for support. Individuals from underrepresented racial and ethnic
groups as well as individuals with disabilities are always encouraged to apply
for NIH support.
For institutions/organizations proposing multiple PDs/PIs, visit the Multiple
Program Director/Principal Investigator Policy and submission details in the Senior/Key
Person Profile (Expanded) Component of the SF 424 (R&R) Application Guide.
The PD/PI should be an established investigator in the scientific area in which
the application is targeted and capable of providing both administrative and
scientific leadership to the development and implementation of the proposed
program. The PD/PI will be expected to monitor and assess the program and
submit all documents and reports as required.
The PD/PI at the institution will be responsible for the appointment of the K12 scholars and for the overall direction, management and administration of the program. It is expected that the PD/PI will be a pediatric endocrinologist with a strong record in biomedical research and mentoring. If the program director is not a pediatric diabetologist, a senior investigator with expertise in pediatric diabetes research must be included as a part of the leadership in the K12 program.
This FOA does not require cost sharing as defined in the NIH Grants Policy Statement.
Only one application per institution is allowed. NIH will not accept any application in response to this FOA that is essentially the same as one currently pending initial peer review unless the applicant withdraws the pending application. NIH will not accept any application that is essentially the same as one already reviewed.
Researchers from diverse backgrounds, including racial and ethnic minorities, persons with disabilities, and women are encouraged to participate as mentors. Mentors should have research expertise and experience relevant to the proposed program. Mentors must be committed to continue their involvement throughout the total period of the mentee’s participation in this award. Scholars appointed to the training programs must name a primary mentor, who together with the appointee is responsible for the planning, direction, and execution of the individual career development program. The mentor should be recognized as an accomplished investigator in the proposed research area, which should be relevant to type 1 diabetes, and have a track record of success in training independent investigators. The mentor should have sufficient independent research support to cover the costs of the proposed research project in excess of the allowable costs of this award. Scholars may also nominate co-mentors, as appropriate to the goals of the program.
Scholars to be supported by the institutional career
development program must be at the career level for which the planned program
is intended. Scholars are expected to devote a minimum level of effort of 9
person months (75% of full-time professional effort) during the entire appointment
on the K12 award.
By the time of award, each scholar must be a citizen or a non-citizen
national of the United States or have been lawfully admitted for permanent
residence (i.e., possess a currently valid Permanent Resident Card USCIS Form
I-551, or other legal verification of such status).
Scholars appointed to the K12 program must have the opportunity to carry out supervised basic or clinical biomedical or behavioral research relevant to type 1 diabetes with the primary objective of developing or extending their research skills and knowledge in preparation for an independent research career in pediatric diabetes.
Scholars appointed to the K12 career development program must be physician scientists who have completed their pediatric endocrinology fellowship training. NIDDK anticipates that all physician scientist scholars appointed to the K12 career development program will be either board-certified or board eligible. The scholars may spend up to three years in the K12 career development program, but are strongly encouraged to apply for either an individual Mentored Clinical Scientist Research Career Development Award (K08; http://grants.nih.gov/grants/guide/pa-files/PA-10-059.html) or an individual Mentored Patient-Oriented Research Career Development Award (K23; http://grants.nih.gov/grants/guide/pa-files/PA-10-060.html) after 1-2 years of support through the K12 program. The physician scientist may receive up to a total of 6 years of combined support through the K12 and K08/K23 grant mechanisms.
At the time of initial K12 appointment, scholars should have no more than five years of postdoctoral research experience and not more than 10 years should have elapsed since receiving the terminal doctoral degree. Time spent in clinical training is not considered postdoctoral research training. Mid-career and senior faculty are not eligible.
Applicants should include a plan describing selection procedures for recruiting scholars. These plans should include recruiting efforts to enhance diversity. The applicant institution may request support for two to three scholars in each budget period. Appointments of scholars may occur at any point during the current budget period, but scholar appointments that are not filled during the current budget period may not be carried forward into a subsequent budget period. Institutions are encouraged to design a program that is appropriate for their pool of potential scholars and participating faculty/mentors. The award provides support to institutions for up to five consecutive 12-month periods. Appointments are provided in 12-month increments; appointments of less than 9 months require prior approval from NIDDK.
Individuals who are or were Principal Investigators on NIH Small Research Grants (i.e., R03s) or Exploratory/Developmental Research Grants (i.e., R21s) are eligible for K12 support providing they do not have more than 5 years of postdoctoral research experience and not more than 10 years has elapsed since the granting of the terminal doctoral degree as described above. However, individuals who are or were Principal Investigators on NIH research projects grants (R01), sub-projects of program projects (P01) or Center grants (P50) or the equivalent are not eligible for appointment under this K12 program. Individuals who have been previously supported by NIH or non-NIH career development awards are not eligible. Scholars may not concurrently hold any other PHS award that duplicates the provisions of this award.
Applicants must download the SF424 (R&R) application package associated with this funding opportunity using the Apply for Grant Electronically button in this FOA or following the directions provided at Grants.gov.
It is critical that applicants follow the instructions in
the SF424
(R&R) Application Guide, except where instructed in this funding
opportunity announcement to do otherwise. Conformance to the requirements in
the Application Guide is required and strictly enforced. Applications that are
out of compliance with these instructions may be delayed or not accepted for
review.
For information on Application Submission and Receipt, visit Frequently
Asked Questions Application Guide, Electronic Submission of Grant
Applications.
Letter of Intent
Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information that it contains allows IC staff to estimate the potential review workload and plan the review.
By the date listed in Part 1. Overview Information, prospective applicants are asked to submit a letter of intent that includes the following information:
Descriptive title of proposed research
Name, address, and telephone number of the PD(s)/PI(s)
Names of other key personnel
Participating institutions
Number and title of this funding opportunity
The letter of intent should be sent to:
Francisco O. Calvo, Ph.D.
Chief, Review Branch
National Institute of Diabetes and Digestive and
Kidney Diseases
6707 Democracy Boulevard, Room 752
Bethesda, MD 20892-5452
(for express/courier service: Bethesda, MD 20817)
Telephone: 301-594-8897
Email: [email protected]
The forms package associated with this FOA includes all applicable components, mandatory and optional. Please note that some components marked optional in the application package are required for application submission. Follow the instructions in the SF 424 (R&R) Application Guide to determine which components are required.
All page limitations described in the SF424 (R&R) Application Guide and the Table of Page Limits must be followed.
All instructions provided in the SF424 (R&R) Application Guide must be followed,with the following modifications:
Substitute all references to trainees in the SF 424 (R&R) Application Guide with scholars and all references to training in the SF 424 (R&R) Application Guide with career development .
Project Summary/Abstract
Provide an abstract of the entire application, including the long-term goals and objectives of the program, key elements of the career development plan, and brief descriptions of planned research projects. Include the rationale and design of the program, the planned duration and projected number of scholars, including their levels (i.e., postdoctoral, faculty).
Advisory Committee (Uploaded via the Other Attachments section)
A plan must be provided for the appointment of an Advisory Committee to monitor progress of the program. Composition, responsibilities, frequency of meetings, and other relevant information should be included. Describe the composition of the Advisory Committee, identifying the role and the desired expertise of members. A plan for Advisory Committee approval and selection of participants should be included. Describe how the Advisory Committee will function in providing oversight of the development, implementation, and evaluation of recruitment strategies, the recruitment and retention of candidates, and the evaluation of the overall effectiveness of the program. Note that Advisory Committee members should not be named in the application, particularly if they include individuals from outside the institution.
The filename provided for each Other Attachment will be the name used for the bookmark in the electronic application in eRA Commons.
Follow all instructions provided in the SF424 (R&R) Application Guide with the following modifications:
All Supplemental Instructions to the SF424 (R&R) for Preparing Institutional Ruth L. Kirschstein National Research Service Award (NRSA) Application must be followed, with the additional instructions described below:
Program Administration (Component of Program Plan)
Describe the acknowledged strengths, leadership and administrative skills, and scientific expertise of the PD/PI. Include active research and the planned strategy to be used to oversee and monitor the program. For applications with multiple PDs/PI(s), address the Leadership Plan and how the combined knowledge, skills and experience of the individual PDs/PIs will enhance the likelihood of success of the program. When a program administrator position is planned, a description of the scientific expertise, leadership, and administrative capabilities essential to coordinate a program for developing investigators must be included in the application..
Program Faculty (Component of Program Plan)
Describe the complementary expertise and experiences of the proposed mentors for the scholars. Include active research and other scholarly activities in which the mentors are engaged, as well as track records of mentoring and training.
Proposed Training (Component of Program Plan)
Provide an overview of the proposed program: Describe the immediate and long-term objectives of the program, including training or career development activities that will be used to ensure that the objectives of the program are met. Include information about planned courses, curricula, seminars, workshops, or tutorials that will be incorporated into the training program and mentored research experiences and activities. Institutions with existing training or career development programs must explain what distinguishes this proposal from the others, how the programs will synergize, if applicable, and make it clear that the faculty, potential trainees, and resources are robust enough to support additional programs. The description should include planned strategies to be used to ensure that the objectives are met. The PD/PI should also describe past research career development activities/experiences including those of mentors, documenting the success of former scholars in establishing independent productive scientific careers. Programs should provide all trainees with additional professional development skills and career guidance including instruction and training in grant writing in order to apply successfully for future career development and independent research support. All postdoctoral trainees should also be provided with instruction in laboratory and project management.
Program Evaluation (Component of Program Plan)
Describe an evaluation plan to review and determine the effectiveness of the program. This should include plans to obtain feedback from current and former scholars to help identify weaknesses and to provide suggestions for program improvements, as well as plans for assessing scholars career development and progression including degree completion (if applicable), publications, and subsequent positions. Evaluation results should be included in future competing continuation (renewal) applications and as part of the Final Progress Report.
Scholar Candidates (Component of Program Plan)
Describe in general terms the pool of potential candidates including information about the types of prior clinical and research training and career level required for the program.. Describe the criteria to be used for candidate evaluation in the selection ofScholars. Describe plans to recruit candidates, including those from economically, socially, or culturally disadvantaged backgrounds, individuals with disabilities or from racial or ethnic groups that are currently underrepresented in biomedical, behavioral, or clinical sciences and explain how these plans will be implemented. Provide brief summaries of training plans that the program will employ. The application should contain a description of how the career development plan will be tailored to the needs of the prospective candidates, taking into account their past experiences and competences, and should distinguish the plan from fellowship training. PDs/PIs should submit a plan for recruiting scholars from both outside and inside the sponsoring institution. The appointment of Scholars should be documented by a Statement of Appointment Form (Form 2271) and submitted to the funding IC.
Institutional Environment and Commitment to the Program (Component of Program Plan)
The application must include a statement from the applicant institution describing the commitment to the planned program. The institution must assure that essential time will be allowed for the PDs/PIs, other faculty and mentors , and the required protected time for scholars (9 person months, equivalent to 75%) selected for the program.
Applicants who previously received K12 support through the NIDDK as part of a broader initiative (Training Programs in Diabetes Research for Pediatric Endocrinologists), or who had a similar institutional program in the past 5-10 years, should include a narrative report of the accomplishments from their previous program. Specific data regarding the numbers of pediatric endocrinology scholars supported and their K12 accomplishments (e.g. research publications, subsequent grant support, and current position) are generally very valuable information for reviewers when evaluating the training record of the proposed new program.
Appendix
Do not use the appendix to circumvent page limits. Follow all instructions for the Appendix as described in the SF424 (R&R) Application Guide.
Part I. Overview Information contains information about Key Dates. Applicants are encouraged to submit in
advance of the deadline to ensure they have time to make any application
corrections that might be necessary for successful submission.
Organizations must submit applications via Grants.gov, the online portal to find and apply for grants
across all Federal agencies. Applicants must then complete the submission
process by tracking the status of the application in the eRA Commons, NIH’s electronic system for grants
administration.
Applicants are
responsible for viewing their application in the eRA Commons to ensure accurate
and successful submission.
Information on the submission process and a definition of on-time
submission are provided in the SF424 (R&R) Application Guide.
This initiative is not subject to intergovernmental review.
All NIH awards are subject to the terms and conditions, cost
principles, and other considerations described in the NIH Grants Policy
Statement.
Pre-award costs are allowable only as described in the NIH Grants
Policy Statement.
Applications must be submitted electronically following the instructions described in the SF 424 (R&R) Application Guide. Paper applications will not be accepted.
Applicants must complete all required registrations before the application due date. Section III. Eligibility Information contains information about registration.
For assistance with your electronic application or for more information on the electronic submission process, visit Applying Electronically.
Important reminders:
All PD/PIs must include their eRA Commons ID in the
Credential field of the Senior/Key Person Profile Component of the SF
424(R&R) Application Package. Failure to register in the Commons and
to include a valid PD/PI Commons ID in the credential field will prevent the
successful submission of an electronic application to NIH.
The applicant organization must ensure that the DUNS number it provides on the
application is the same number used in the organization’s profile in the eRA
Commons and for the Central Contractor Registration (CCR). Additional
information may be found in the SF424 (R&R) Application Guide.
See more
tips for avoiding common errors.
Upon receipt, applications will be evaluated for completeness by the Center for Scientific Review and responsiveness by NIDDK, NIH. Applications that are incomplete and/or nonresponsive will not be reviewed.
In order to expedite review, applicants are requested to notify the NIDDK Referral Office by email at [email protected] when the application has been submitted. Please include the FOA number and title, PD/PI name, and title of the application.
Applicants are required to follow the instructions for post-submission materials, as described in NOT-OD-10-115..
Only the review criteria described below will be considered in the review process. As part of the NIH mission, all applications submitted to the NIH in support of biomedical and behavioral research are evaluated for scientific and technical merit through the NIH peer review system.
Reviewers will provide an overall impact/priority score to reflect their assessment of the likelihood for the program to exert a sustained, powerful influence on the research field(s) involved, in consideration of the following review criteria and additional review criteria (as applicable for the project proposed).
Reviewers will consider each of the review criteria below in the determination of scientific merit, and give a separate score for each. An application does not need to be strong in all categories to be judged likely to have major scientific impact.
Career Development Program and Environment
Does the proposed program clearly outline a plan to recruit and develop well-qualified junior investigators for successful careers as biomedical or clinical researchers? Is there evidence of an adequate pool of potential scholars who could benefit from receiving career development support? Are the content and duration of any proposed didactic, training-related, and research-related activities of the program appropriate? Are appropriate timelines indicated for career progression and transition to independence? Does the institutional environment (e.g., research facilities and other relevant resources) in which the program will be conducted contribute to the probability of success? Does the proposed career development program benefit from unique features of the scientific environment, subject populations, or employ useful collaborative arrangements? Is the institutional commitment to the proposed program appropriate? If multiple sites are participating, is this adequately justified in terms of the career development and research experiences provided? Is there sufficient assurance that the required effort of the PD/PI, mentors and scholars will be devoted directly to the research training, career development, and related activities? When applicable, is there adequate documentation describing the responsibilities of the advisory committee with regard to the provision of input, guidance and oversight of the program?
Program Director(s)/Principal Investigator(s) (PDs/PIs)
Do the PD/PI and Research Administrator (if applicable), have the experience to develop, direct and administer the proposed program? Does the leadership team bring complementary and integrated expertise to the program? Is there evidence that an appropriate level of effort will be devoted by the program leadership to ensure program objectives? Are the research qualifications, scientific stature, previous leadership and mentoring experience, and track record(s) appropriate for the proposed career development program? Are the PD(s)/PI(s) currently engaged in research relevant to the scientific area of the proposed program?
Mentors
Do the mentors have expertise and experience, as well as track records of past mentoring and training? Are the quality and extent of the mentors roles in providing guidance and scientific advice to the scholars acceptable? Are the mentors currently engaged in research relevant to type 1 diabetes?
Candidates/Scholars
What is the quality of plans to identify, recruit, and select candidates, with a commitment to research relevant to the mission of the FOA, and the potential to develop as independent researchers? Is there an appropriate plan for the content, the phasing, and the proposed duration of the career development plan for achieving scientific independence for the prospective candidates? How useful is the research plan as a vehicle for ensuring research training for all scholars as described in the career development plan? What is the likelihood that the career development plan will contribute significantly to the scientific development of the scholars? Does the program include a plan to recruit, identify, and select scholars with a commitment to research relevant to the objectives of the FOA? Does the plan for selection of the scholars include all of the eligibility criteria stated in the FOA?
Are there formal and informal programmatic activities to enhance interactions among the scholars? Are there plans for programmatic enrichment activities, and are these plans appropriate for enhancement of the training of the expected scholars at the institution?
Training Record
Does the program have a rigorous evaluation plan to assess the quality and effectiveness of the training?
Does the program have a track record and success in recruiting scholars and retaining them in research careers?
As applicable for the project proposed, reviewers will evaluate the following additional items while determining scientific and technical merit, and in providing an overall impact/priority score, but will not give separate scores for these items.
Protections for Human Subjects
Generally not applicable. Reviewers should bring any concerns to the attention of the Scientific Review Officer.
Inclusion of Women, Minorities, and Children
Generally not applicable. Reviewers should bring any concerns to the attention of the Scientific Review Officer.
Vertebrate Animals
Generally not applicable. Reviewers should bring any concerns to the attention of the Scientific Review Officer.
Biohazards
Generally not applicable. Reviewers should bring any concerns to the attention of the Scientific Review Officer.
Resubmissions
Not Applicable.
Renewals
Not Applicable.
Revisions
Not applicable.
As applicable for the project proposed, reviewers will consider each of the following items, but will not give scores for these items, and should not consider them in providing an overall impact/priority score.
Recruitment & Retention Plan to Enhance Diversity
Peer reviewers will separately evaluate the recruitment and retention plan to enhance diversity after the overall score has been determined. Reviewers will examine the strategies to be used in the recruitment and retention of individuals from underrepresented groups. The review panel’s evaluation will be included in an administrative note in the summary statement.
Training in the Responsible Conduct of Research
Taking into account the specific characteristics of the career development program, level of scholar experience, and the particular circumstances of the scholars, the reviewers will address the following questions. Does the plan satisfactorily address the format of instruction, e.g. lectures, coursework and/or real-time discussion groups? Do plans include a sufficiently broad selection of subject matter, such as conflict of interest, authorship, data management, human subjects and animal use, laboratory safety? Do the plans adequately describe how faculty will participate in the instruction? Does the plan meet the minimum requirements for RCR, i.e., eight contact hours of instruction every four years? Plans and past record will be rated as acceptable or unacceptable, and the summary statement will provide the consensus rating of the review committee. Applications rated unacceptable will not be funded until the applicant provides an acceptable, revised plan.
Select Agent Research
Reviewers will assess the information provided in this section of the application, including 1) the Select Agent(s) to be used in the proposed research, 2) the registration status of all entities where Select Agent(s) will be used, 3) the procedures that will be used to monitor possession use and transfer of Select Agent(s), and 4) plans for appropriate biosafety, biocontainment, and security of the Select Agent(s).
Budget and Period of Support
Reviewers will consider whether the budget and the requested period of support are fully justified and reasonable in relation to the proposed research.
Applications will be evaluated for scientific and technical
merit by (an) appropriate Scientific Review Group(s) convened by the NIDDK (assignments will be shown in the eRA Commons), in accordance with NIH peer
review policy and procedures, using the stated review
criteria.
As part of the scientific peer review, all applications:
Applications will be assigned to the appropriate NIH Institute or Center. Applications will compete for available funds with all other recommended applications submitted in response to this FOA . Following initial peer review, recommended applications will receive a second level of review by the National Diabetes and Digestive and Kidney Diseases Advisory Council . The following will be considered in making funding decisions:
After the peer review of the application is completed, the
PD/PI will be able to access his or her Summary Statement (written critique)
via the eRA
Commons.
Information regarding the disposition of applications is available in the NIH Grants
Policy Statement.
If the application is under consideration for funding, NIH
will request "just-in-time" information from the applicant as
described in the NIH Grants
Policy Statement.
A formal notification in the form of a Notice of Award (NoA) will be provided
to the applicant organization for successful applications. The NoA signed by
the grants management officer is the authorizing document and will be sent via
email to the grantee business official.
Awardees must comply with any funding restrictions described in Section IV.5. Funding Restrictions. Selection
of an application for award is not an authorization to begin performance. Any
costs incurred before receipt of the NoA are at the recipient's risk. These
costs may be reimbursed only to the extent considered allowable pre-award costs.
Any application awarded in response to this FOA will be subject to the DUNS,
CCR Registration, and Transparency Act requirements as noted on the Award
Conditions and Information for NIH Grants website.
All NIH grant and cooperative agreement awards include the NIH Grants Policy Statement as part of the NoA. For these terms of award, see the NIH Grants Policy Statement Part II: Terms and Conditions of NIH Grant Awards, Subpart A: General and Part II: Terms and Conditions of NIH Grant Awards, Subpart B: Terms and Conditions for Specific Types of Grants, Grantees, and Activities. More information is provided at Award Conditions and Information for NIH Grants.
In carrying out its stewardship of human resource-related programs, the NIH may request information essential to an assessment of the effectiveness of this program. Accordingly,scholars are hereby notified that they may be contacted after the completion of this award for periodic updates on various aspects of their employment history, publications, support from research grants or contracts, honors and awards, professional activities, and other information helpful in evaluating the impact of the program.
Not Applicable.
The Non-Competing
Continuation Grant Progress Report (PHS 2590) and financial statements (Financial
Status Report) as described in the NIH Grants
Policy Statement are required annually. Continuation support will not be
provided until the required forms are submitted and accepted. Additional
Instructions for Preparing a Progress Report for an Institutional Research Training
Grant, including Ruth L. Kirschstein National Research Service Awards, must be
followed.
Failure by the grantee institution to submit required forms
in a timely, complete, and accurate manner may result in an expenditure
disallowance or a delay in any continuation funding for the award.
The Federal Funding Accountability and Transparency Act of 2006 (Transparency Act), includes a requirement for awardees of Federal grants to report information about first-tier subawards and executive compensation under Federal assistance awards issued in FY2011 or later. All awardees of applicable NIH grants and cooperative agreements are required to report to the Federal Subaward Reporting System (FSRS) available at www.fsrs.gov on all subawards over $25,000. See the NIH Grants Policy Statement for additional information on this reporting requirement.
A final progress report, invention statement, and Financial Status Report are required when an award is relinquished, when a recipient changes institutions, or when an award is terminated.
We encourage inquiries concerning this funding opportunity and welcome the opportunity to answer questions from potential applicants.
Grants.gov
Customer Support (Questions regarding Grants.gov registration and
submission, downloading or navigating forms)
Contact Center Phone: 800-518-4726
Email: [email protected]
GrantsInfo (Questions regarding application instructions and
process, finding NIH grant resources)
Telephone 301-710-0267
TTY 301-451-5936
Email: [email protected]
eRA Commons Help Desk(Questions regarding eRA Commons
registration, tracking application status, post submission issues)
Phone: 301-402-7469 or 866-504-9552 (Toll Free)
TTY: 301-451-5939
Email: [email protected]
James F. Hyde, Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases(NIDDK)
Telephone: 301-594-7692
Email: [email protected]
Francisco O. Calvo, Ph.D.
Chief, Review Branch
National Institute of Diabetes and Digestive and Kidney
Diseases (NIDDK)
Telephone: 301-594-8897
Email: [email protected]
Aricia M. Ajose, MPA
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-594-9023
Email:[email protected]
Recently issued trans-NIH policy notices may affect your application submission. A full list of policy notices published by NIH is provided in the NIH Guide for Grants and Contracts. All awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement.
Awards are made under the authorization of Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 45 CFR Parts 74 and 92.
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
|
| ||||||
|
|
|
Department of Health and Human Services (HHS) |
|
|||
|
NIH... Turning Discovery Into Health® |
||||||